Back

Low mortality in AdaptResponse compared to historical pharmacological and CRT trials in heart failure with reduced ejection fraction

12 May 2024 (11:40 - 11:48)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: devices Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

15 More presentations in this session

Presentation thumbnail
Correlation of the non-invasive cardiopulmonary management wearable device with measures of congestion in Heart Failure study
Doctor J. Curtain (Dublin, IE)
Slides Video
Presentation thumbnail
Discussant review - CONGEST-HF
Doctor C. Kapelios (Athens, GR)
Slides Video
Presentation thumbnail
A Prospective, Multi-center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients
Professor M. Kiernan (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - PROACTIVE-HF
Professor M. Piepoli (San Donato Milanese, IT)
Slides Video
Presentation thumbnail
REducing Lung congestIon symptoms using the v-wavE shunt in adVancEd Heart Failure
Professor S. Anker (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials: devices
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - AdaptResponse Randomized Clinical Trial
thumbnail
Congress Session
Late breaking clinical trials: devices
thumbnail
Congress Presentation
Event rates in major phase 3 heart failure trials over the past 20 years

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources